International Thyroid Congress

Dr. Paul Walfish on PD-1 Expression in Thyroid Cancer

October 24, 2015

Paul Walfish, MD, professor emeritus at the University of Toronto School of Medicine, senior consult Mount Sinai Hospital discusses programmed death ligand 1 (PD-1) expression in aggressive metastatic papillary thyroid cancer.

Dr. Michael Tuttle on Dosimetry Versus Empiric Dosing Radioactive Iodine Treatment

October 23, 2015

Michael Tuttle, MD, endocrinologist Memorial Sloan Kettering (MSK), discusses best management approaches to radioactive iodine treatment in patients with radioiodine avid distant metastases from differentiated thyroid cancer.